Report Code : CVMI2603252601524 | Published Date : March 30, 2025

1 | Market Overview

The antibody production market forms the cornerstone of modern therapeutic, diagnostic, and research-based biotechnology. As monoclonal antibodies (mAbs) and polyclonal antibodies gain traction in immunotherapy, cancer treatment, autoimmune diseases, and infectious disease management, the demand for scalable, high-yield, and cost-effective antibody manufacturing platforms continues to accelerate. Key developments such as CHO cell-line engineering, single-use bioreactors, and continuous bioprocessing are revolutionizing both upstream and downstream workflows. Governments, CROs, and biotech firms are increasing investments in biomanufacturing infrastructure, particularly in North America, Europe, and Asia-Pacific, to ensure rapid response capabilities and supply-chain resilience.

 

2 | Market Size and Forecast

Year

Market Value (USD billion)

Notes

2019

10.3

Established baseline from biologics manufacturing data

2024

18.1

CAGR 11.7% (2019–2024)

2031

41.2

CAGR 12.6% (2024–2031)

The expansion of biosimilar pipelines, contract manufacturing demand, and rapid diagnostic testing for emerging pathogens underpins growth. Scenario analyses suggest that integration of AI-based process optimization could push the 2031 value to USD 45 billion.

 

3 | Primary Market Drivers

  • Therapeutic demand: Increase in approved mAbs for oncology, neurology, and autoimmune indications.
  • Pandemic Preparedness: COVID-19 and Future Zoonotic Threats Elevate the Role of Recombinant Antibody Platforms.
  • Contract biomanufacturing is booming as CDMOs expand capacities for both innovator and biosimilar pipelines.
  • Process innovation: Transition from batch to continuous manufacturing to enhance yield and cost efficiency.
  • Government incentives include subsidies for the production of domestic biologics and the development of regional bioclusters.

 

4 | Market Challenges

  • High cost of development: The transition from preclinical to commercial scale remains capital-intensive.
  • Supply chain volatility: Critical shortages of reagents and dependencies on single sources.
  • Regulatory complexities: Global variations in biosimilar and novel antibody approval frameworks.
  • Scale-up bottlenecks: Maintaining yield and product quality consistency in large-scale operations.
  • Talent shortages: Lack of trained personnel in bioprocessing and biomanufacturing fields.

 

5 | Competitive Landscape

Company

Est. 2024 Share

Strengths

Recent Strategic Move

Lonza

16%

Large-scale mammalian cell facilities

Launched Ibex® Design for faster clinical-scale manufacturing

Samsung Biologics

14%

Flexible capacity, CDMO model

Opened fourth plant doubling antibody production output

Boehringer Ingelheim

11%

Early-phase bioprocessing expertise

Expanded Fremont, CA facility for monoclonal antibody production

WuXi Biologics

10%

Single-use platform leader

Broke ground on Singapore mega facility

Thermo Fisher Scientific

9%

Cell culture media, purification solutions

Acquired Henogen to bolster biologics CDMO services

 

6 | Detailed Market Segmentation

By Type

  • Monoclonal Antibodies (mAbs): 68%
  • Polyclonal Antibodies: XX%
  • Recombinant Antibodies: XX%

 

By Production Method

  • In Vivo
  • In Vitro (dominant due to scalability)

 

By End Use

  • Therapeutics (53%)
  • Research and Academia (XX%)
  • Diagnostics (XX%)

 

By Region

  • North America – 38%
  • Europe – XX%
  • Asia-Pacific – fastest growth
  • Latin America and MEA – emerging markets

 

7 | Technology and Innovation

  • AI-driven process control: Enhances yield prediction and optimizes media composition.
  • Perfusion bioreactors: Allow longer culture durations with higher antibody titers.
  • Cell-line engineering: CRISPR/Cas9 used to fine-tune CHO productivity and glycosylation patterns.
  • Automated downstream purification: Skid-based chromatography reduces hands-on time and contamination risks.
  • Modular biomanufacturing: Portable cleanrooms and POD-based facilities support rapid deployment.

 

8 | Regulatory Environment

  • FDA and EMA harmonization on biosimilar antibody evaluations has accelerated global market entry.
  • China’s NMPA reforms are reducing approval timelines for local and foreign antibody products.
  • WHO prequalification is increasingly sought for antibody-based diagnostics and therapies in low-income markets.

 

9 | Strategic Outlook

  • Manufacturers should invest in continuous bioprocessing and modular plants to enhance flexibility.
  • Investors should monitor CDMOs with single-use infrastructure and diverse client portfolios.
  • Policymakers must address reagent supply bottlenecks and support workforce development programs.
  • Innovators must differentiate on glycosylation precision, half-life extension, and downstream scalability.




Reasons To Buy

Image



Scope

Image

Key Players

  • Thermo Fisher Scientific
  • Merck KGaA
  • GE Healthcare
  • Sartorius
  • Abcam
  • Rockland Immunochemicals
  • Bio-Rad Laboratories

 

Global Antibody Production Market Report

  1. 1. Global Antibody Production Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Antibody Production Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Antibody Production Market Research Report - Preface
    1. 2.1 Global Antibody Production Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Process
      2. 2.1.2 By Type
      3. 2.1.3 By End-User
      4. 2.1.4 By Region
    3. Global Antibody Production Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Process, By Type, By End-User, By Country
    3. 3.3. Opportunities – By Process, By Type, By End-User, By Country
    4. 3.4. Trends – By Process, By Type, By End-User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Antibody Production Market Research Report – DROTs Impact Analysis
    4. Global Antibody Production Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Antibody Production Market, By Process, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Upstream Processing
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Downstream Processing
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Fill-Finish Processing
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Antibody Production Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Monoclonal Antibodies
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Polyclonal Antibodies
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Antibody Production Market, By End-User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Pharmaceutical & Biotechnology Companies
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Research Laboratories
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 CROs
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Antibody Production Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 8.5 Middle East & Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 8.6 Global Antibody Production Market - Opportunity Analysis Index, By Process, By Type, By End-User, and Region, 2024 - 2031
    9. North America Global Antibody Production Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Process Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Upstream Processing
      2. 9.1.2 Downstream Processing
      3. 9.1.3 Fill-Finish Processing
      9.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Monoclonal Antibodies
      2. 9.2.2 Polyclonal Antibodies
      9.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Pharmaceutical & Biotechnology Companies
      2. 9.3.2 Research Laboratories
      3. 9.3.3 CROs
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
      9.5 North America Global Antibody Production Market – Opportunity Analysis Index, By Process, By Type, By End-User, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 North America Global Antibody Production Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Global Antibody Production Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Process Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Upstream Processing
      2. 10.1.2 Downstream Processing
      3. 10.1.3 Fill-Finish Processing
      10.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Monoclonal Antibodies
      2. 10.2.2 Polyclonal Antibodies
      10.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Pharmaceutical & Biotechnology Companies
      2. 10.3.2 Research Laboratories
      3. 10.3.3 CROs
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands
      8. 10.4.8 Poland
      9. 10.4.9 Rest of Europe
      10.5 Europe Global Antibody Production Market – Opportunity Analysis Index, By Process, By Type, By End-User, and Country, 2024 - 2031
      10.6 Regional Trends Analysis
      10.7 Europe Global Antibody Production Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Global Antibody Production Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Process Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Upstream Processing
      2. 11.1.2 Downstream Processing
      3. 11.1.3 Fill-Finish Processing
      11.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Monoclonal Antibodies
      2. 11.2.2 Polyclonal Antibodies
      11.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Pharmaceutical & Biotechnology Companies
      2. 11.3.2 Research Laboratories
      3. 11.3.3 CROs
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & NZ
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
      11.5 Asia-Pacific Global Antibody Production Market – Opportunity Analysis Index, By Process, By Type, By End-User, and Country, 2024 - 2031
      11.6 Regional Trends Analysis
      11.7 Asia-Pacific Global Antibody Production Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Global Antibody Production Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Process Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Upstream Processing
      2. 12.1.2 Downstream Processing
      3. 12.1.3 Fill-Finish Processing
      12.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Monoclonal Antibodies
      2. 12.2.2 Polyclonal Antibodies
      12.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Pharmaceutical & Biotechnology Companies
      2. 12.3.2 Research Laboratories
      3. 12.3.3 CROs
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
      12.5 Latin America Global Antibody Production Market – Opportunity Analysis Index, By Process, By Type, By End-User, and Country, 2024 - 2031
      12.6 Regional Trends Analysis
      12.7 Latin America Global Antibody Production Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East & Africa Global Antibody Production Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Process Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Upstream Processing
      2. 13.1.2 Downstream Processing
      3. 13.1.3 Fill-Finish Processing
      13.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Monoclonal Antibodies
      2. 13.2.2 Polyclonal Antibodies
      13.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Pharmaceutical & Biotechnology Companies
      2. 13.3.2 Research Laboratories
      3. 13.3.3 CROs
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
      13.5 Middle East & Africa Global Antibody Production Market – Opportunity Analysis Index, By Process, By Type, By End-User, and Country, 2024 - 2031
      13.6 Regional Trends Analysis
      13.7 Middle East & Africa Global Antibody Production Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
      14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Thermo Fisher Scientific
      2. 14.2.2 Merck KGaA
      3. 14.2.3 GE Healthcare
      4. 14.2.4 Sartorius
      5. 14.2.5 Abcam
      6. 14.2.6 Rockland Immunochemicals
      7. 14.2.7 Bio-Rad Laboratories
    15. Data Collection Method and Research Approach
    16. Principal Presumptions and Acronyms





    2.  
  2.  
  3.